Detalles de la búsqueda
1.
Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.
Breast Cancer Res Treat
; 154(2): 275-86, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26493064
2.
Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru.
Front Oncol
; 13: 1227864, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37664050
3.
Status of breast cancer in Latin American: Results of the breast cancer revealed initiative.
Crit Rev Oncol Hematol
; 181: 103890, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36462594
4.
Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes.
Cancers (Basel)
; 14(17)2022 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077821
5.
Implementing HPV testing in 9 Latin American countries: The laboratory perspective as observed in the ESTAMPA study.
Front Med (Lausanne)
; 9: 1006038, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36465901
6.
Recommendations for streamlining precision medicine in breast cancer care in Latin America.
Cancer Rep (Hoboken)
; 4(6): e1400, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33939336
7.
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer.
Sci Rep
; 8(1): 4899, 2018 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29559701
8.
Herbal Medicine Practices of Patients With Liver Cancer in Peru: A Comprehensive Study Toward Integrative Cancer Management.
Integr Cancer Ther
; 17(1): 52-64, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28088871
9.
Automated segmentation and classification of cell nuclei in immunohistochemical breast cancer images with estrogen receptor marker.
Annu Int Conf IEEE Eng Med Biol Soc
; 2016: 2399-2402, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28268808
10.
Hepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru.
Heliyon
; 2(1): e00052, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27441236
11.
A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease.
NPJ Genom Med
; 1: 15015, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-29263808
12.
Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer.
Oncotarget
; 7(15): 20282-92, 2016 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26958810
13.
Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence.
Sci Transl Med
; 8(334): 334ra53, 2016 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27075627
14.
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors.
Clin Cancer Res
; 22(6): 1499-509, 2016 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26515496
15.
A peculiar mutation spectrum emerging from young peruvian patients with hepatocellular carcinoma.
PLoS One
; 9(12): e114912, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25502816
16.
PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancers.
Hematol Oncol Stem Cell Ther
; 7(4): 142-8, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25467032
17.
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.
Cancer Discov
; 4(2): 232-45, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24356096
18.
Correction: RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors.
Clin Cancer Res
; 25(4): 1437, 2019 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30770496
19.
Topoisomerase II-α as a predictive factor of response to therapy with anthracyclines in locally advanced breast cancer.
Breast
; 20(1): 39-45, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20705464
20.
Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.
Clin Cancer Res
; 16(21): 5351-61, 2010 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20829329